Definitive Healthcare greatly expands all-payor medical and prescription claims coverage

Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) reported a 60% increase in its Atlas Prescription Claims and significant growth in Atlas All-Payor Claims. This expansion enhances data for healthcare providers to improve patient outcomes, particularly in areas like rare diseases and oncology, with nearly 20% increases in these sectors. CEO Robert Musslewhite emphasized the value of the expanded dataset for driving commercial success, refining methodologies, and increasing patient cohort accuracy. The updated Atlas Dataset equips clients with comprehensive insights into patient care, provider behavior, and market trends.

Positive

• 60% increase in Atlas Prescription Claims.
• Nearly 20% growth in key healthcare sectors like rare disease and oncology.
• Refined methodologies leading to improved data accuracy and reporting capabilities.
• Expanded dataset provides clients with better insights into patient journeys.

Negative

• None.

60% increase in Atlas Prescription Claims and a significant increase in Atlas All-Payor Claims provides clients with a more in-depth and holistic look at patient care across the healthcare continuum

FRAMINGHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced expanded coverage of its prescription and all-payor medical claims data in the Atlas Dataset. The company’s Atlas Prescription Claims coverage increased by more than 60%, and its Atlas All-Payor Claims coverage also increased significantly, including nearly 20% increases in key areas such as rare disease, oncology, and chronic conditions.

With expanded claims data, any organization partnering with healthcare providers to improve patient care and outcomes can view an in-depth and holistic look at the patient journey across the healthcare continuum to better understand market trends, inform product development, and optimize go-to-market strategy.

“The Atlas Dataset is the foundation of our healthcare commercial intelligence, and the expanded coverage of both prescription and all-payor claims will help our clients accelerate their path to commercial success,” said Robert Musslewhite, CEO of Definitive Healthcare. “We’re excited to increase both the quantity and quality of our Atlas claims datasets to paint a more comprehensive picture of a patient’s journey as part of our ongoing strategy to invest in powerful, real-world data. With the Atlas Dataset, our life sciences customers can more easily and quickly get their drugs and devices to the patients that need them.”

Along with the increased claims volume, Definitive Healthcare refined its methodologies to master payor and patient data to drive increased precision and implemented additional layers of cleansing techniques to enable more detailed and granular reporting, longitudinal and referral analysis, and increased accuracy for patient cohort creation. As a result of the improved underlying methodology and adding new sources, Definitive Healthcare nearly doubled the size of its patient overlap across datasets.

When coupled with the broader Atlas Dataset, including best-in-class affiliations and reference data, the new claims assets provide Definitive Healthcare customers with industry-leading intelligence on provider behavior, providers’ affiliation and referral patterns, patient care, and the activities taking place within a facility.

To learn more about the Atlas All-Payor Claims and Atlas Prescription Claims, visit: https://www.definitivehc.com/data-products/claims

About Definitive Healthcare 

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com. 

Media Contacts:
Danielle Johns
djohns@definitivehc.com

Highwire PR:
definitivehealthcare@highwirepr.com 

Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com

FAQ

What is the recent performance of Definitive Healthcare's Atlas Dataset?

Definitive Healthcare reported a 60% increase in Atlas Prescription Claims and nearly 20% growth in major areas including rare diseases and oncology.

How does the Atlas Dataset enhance patient care?

The expanded claims data offers a comprehensive overview of patient journeys, assisting healthcare providers in improving outcomes and understanding market trends.

What does the CEO of Definitive Healthcare say about the dataset expansion?

CEO Robert Musslewhite highlighted that the expanded coverage will help clients accelerate their path to commercial success.

How does Definitive Healthcare ensure data accuracy in its claims?

The company refined its methodologies and implemented additional cleansing techniques to enhance data precision and reporting.

What are the implications of the claims data expansion for life sciences customers?

Life sciences customers can better align their product development and market strategies to meet the needs of patients.